Akebia Therapeutics Inc
SWB:AX9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Akebia Therapeutics Inc
SWB:AX9
|
US |
|
C
|
Cameco Corp
SWB:CJ6
|
CA |
|
L
|
LVMH Moet Hennessy Louis Vuitton SE
XHAM:MOH
|
FR |
|
C
|
CITIC Securities Co Ltd
HKEX:6030
|
CN |
|
P
|
Penske Automotive Group Inc
SWB:UA9
|
US |
|
C
|
China Petroleum & Chemical Corp
XBER:CHU
|
CN |
|
First Majestic Silver Corp
TSX:FR
|
CA |
|
Lennar Corp
F:LNN0
|
US |
|
S
|
SoftBank Group Corp
F:SFTU
|
JP |
|
Huatai Securities Co Ltd
F:206H
|
CN |
|
A
|
American International Group Inc
LSE:0OAL
|
US |
|
W
|
Waters Corp
DUS:WAZ
|
US |
|
F
|
Fresenius SE & Co KGaA
DUS:FRE
|
DE |
|
ONEOK Inc
NYSE:OKE
|
US |
|
Kirin Holdings Co Ltd
TSE:2503
|
JP |
|
K
|
Kingspan Group PLC
LSE:KGP
|
IE |
|
Secom Co Ltd
TSE:9735
|
JP |
|
S
|
SF Real Estate Investment Trust
HKEX:2191
|
HK |
|
A
|
Ameriprise Financial Inc
BMV:AMP
|
US |
|
C
|
Cameco Corp
DUS:CJ6
|
CA |
|
I
|
Investec Ltd
JSE:INL
|
ZA |
|
H
|
Herbalife Ltd
SWB:HOO
|
KY |
|
M
|
Mitsubishi UFJ Financial Group Inc
XBER:MFZ
|
JP |
|
Immunome Inc
NASDAQ:IMNM
|
US |
Bankruptcy Probability
Akebia Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Akebia Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Akebia Therapeutics Inc
NASDAQ:AKBA
|
307.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
356.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
179.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
75.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
41.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
57.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Akebia Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Akebia Therapeutics Inc has total debt of 176.2m USD. This includes both short-term (0 USD) and long-term (176.2m USD) debt.
You can find a full breakdown on its Balance Sheet.
